Annual Reports

Quarterly Reports


  • 8-K (Feb 28, 2018)
  • 8-K (Feb 20, 2018)
  • 8-K (Feb 1, 2018)
  • 8-K (Jan 30, 2018)
  • 8-K (Jan 25, 2018)
  • 8-K (Dec 22, 2017)


Aetna 8-K 2008

Documents found in this filing:

  1. 8-K
  2. Ex-99
  3. Graphic
  4. Graphic


Washington, D.C. 20549


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):
March 27, 2008
Aetna Logo

Aetna Inc.
(Exact name of registrant as specified in its charter)

(State or other jurisdiction of
(IRS Employer
File Number)
Identification No.)

151 Farmington Avenue, Hartford, CT
(Address of principal executive offices)
(Zip Code)

Registrant’s telephone number, including area code:
(860) 273-0123

Former name or former address, if changed since last report:
Not applicable

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Section 1 – Registrant’s Business and Operations

On March 27, 2008, Aetna Inc. (“Aetna”) entered into an amended and restated unsecured $1.5 billion, five-year revolving credit agreement (the “New Credit Agreement”) with JPMorgan Chase Bank, N.A. (“JPMCB”), as administrative agent, and the 21 lender parties thereto led by JPMCB, Bank of America, N.A., and Citibank N.A.  The New Credit Agreement amends, restates and supersedes Aetna’s $1.0 billion five-year revolving credit agreement, dated as of January 20, 2006 (as previously amended and extended), among Aetna, JPMCB, as administrative agent, and the 20 lender parties thereto (the “Prior Credit Agreement”).  The Prior Credit Agreement was Exhibit 99.1 to Aetna’s Form 8-K filed on January 23, 2006 and was scheduled to expire on January 20, 2012.

The New Credit Agreement is summarized in Item 2.03 of this report, which is incorporated by reference into this Item 1.01.

The administrative agent and certain of the lender parties to the New Credit Agreement perform normal banking, investment banking and/or advisory services for Aetna and its affiliates from time to time for which they have received customary fees and expenses.

A copy of the New Credit Agreement is filed as Exhibit 99.1 to this report and is incorporated herein by reference.

Section 2 – Financial Information

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The New Credit Agreement provides for the granting of revolving loans and the issuance of letters of credit at Aetna’s request, up to a maximum aggregate amount outstanding of $1.5 billion.  Aetna has the option to expand the lenders’ aggregate commitments under the New Credit Agreement to a maximum of $2.0 billion, subject to certain conditions precedent.  The maximum aggregate amount of outstanding letters of credit under the New Credit Agreement is limited to $200 million.  Outstanding letters of credit count as usage of the available commitments under the New Credit Agreement.

The New Credit Agreement expires March 27, 2013; however that expiration date may be extended by one year on each March 27 for the commitments under the New Credit Agreement represented by lenders consenting to such extension, subject to certain conditions precedent.  Various interest rate options are available under the New Credit Agreement.  Any revolving borrowings mature on the termination date of the New Credit Agreement.  Aetna pays facility fees on the lenders’ aggregate commitments under the facility ranging from 0.045% to 0.175% per annum, depending on Aetna’s long-term senior unsecured debt rating.  The facility fee at March 27, 2008 is at an annual rate of 0.06%.

The New Credit Agreement contains customary representations, warranties and covenants, including a financial covenant, for a transaction of this type.  Under the terms of the New Credit Agreement, Aetna is required to maintain its ratio of total debt to adjusted consolidated capitalization as of the end of each fiscal quarter ending on or after December 31, 2007 at or below 0.50 to 1.00.  For this purpose, adjusted consolidated capitalization means the sum of Aetna’s consolidated shareholders’ equity, excluding any adjustment recorded to reflect the overfunded or underfunded status of Aetna’s defined benefit pension and other postretirement plans in accordance with Statement of Financial Accounting Standards No. 158, “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans, an amendment of FASB Statements No. 87, 88, 106 and 132(R),” and any net unrealized capital gains and losses, plus total debt.

The New Credit Agreement also contains customary events of default, including a cross default provision and a change of control provision.  If an event of default occurs that is not otherwise waived or cured, lenders holding a specified percentage of the commitments or outstanding loans may terminate the obligations of the lenders to make loans under the New Credit Agreement and the obligations of the issuing banks to issue letters of credit and/or may declare the loans outstanding under the New Credit Agreement to be due and payable.  Such termination and acceleration will occur automatically in the event of a bankruptcy default.

The foregoing summary of the New Credit Agreement is not complete and is qualified in its entirety by reference to the New Credit Agreement, a copy of which is filed as Exhibit 99.1 to this report and is incorporated herein by reference.  You are encouraged to read the New Credit Agreement.



Section 9 – Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

99.1           $1,500,000,000 Amended and Restated Five-Year Credit Agreement Dated as of March 27, 2008.


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Aetna Inc.

Date: April 1, 2008         
 /s/ Ronald M. Olejniczak
Name: Ronald M. Olejniczak
Title: Vice President and Controller



Exhibit 99.1
$1,500,000,000 Amended and Restated Five-Year Credit Agreement Dated as of March 27, 2008.



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki